Regulatory News
Monday, November 7, 2016
Roche says flexible pricing ready for cancer, not MS drugs
ZURICH, Nov 7 (Reuters) - The spotlight on finding a cancer
cure has spurred improvements in systems to collect and analyze
oncology data, but efforts to track patients with other diseases
lag...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment